Intriguingly, cardiac hypertrophy was augmented in H19 knockout mice following TAC as compared with wild-type littermates, and cardiac-specific overexpression of H19 via vector-based gene therapy ameliorated cardiac dysfunction of TAC-operated mice. This evidence concerns the gene H19 and persistent truncus arteriosus.